1. Home
  2. IH vs ELTX Comparison

IH vs ELTX Comparison

Compare IH & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IH
  • ELTX
  • Stock Information
  • Founded
  • IH 1996
  • ELTX 2011
  • Country
  • IH China
  • ELTX United States
  • Employees
  • IH N/A
  • ELTX N/A
  • Industry
  • IH Other Consumer Services
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IH Real Estate
  • ELTX Health Care
  • Exchange
  • IH Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • IH 146.3M
  • ELTX 121.7M
  • IPO Year
  • IH 2020
  • ELTX N/A
  • Fundamental
  • Price
  • IH $2.82
  • ELTX $11.80
  • Analyst Decision
  • IH
  • ELTX Strong Buy
  • Analyst Count
  • IH 0
  • ELTX 2
  • Target Price
  • IH N/A
  • ELTX $11.00
  • AVG Volume (30 Days)
  • IH 23.9K
  • ELTX 128.2K
  • Earning Date
  • IH 09-26-2025
  • ELTX 08-07-2025
  • Dividend Yield
  • IH 3.04%
  • ELTX N/A
  • EPS Growth
  • IH N/A
  • ELTX N/A
  • EPS
  • IH 0.26
  • ELTX N/A
  • Revenue
  • IH $123,701,096.00
  • ELTX N/A
  • Revenue This Year
  • IH $39.02
  • ELTX N/A
  • Revenue Next Year
  • IH N/A
  • ELTX N/A
  • P/E Ratio
  • IH $10.50
  • ELTX N/A
  • Revenue Growth
  • IH N/A
  • ELTX N/A
  • 52 Week Low
  • IH $1.47
  • ELTX $3.70
  • 52 Week High
  • IH $3.60
  • ELTX $12.42
  • Technical
  • Relative Strength Index (RSI)
  • IH 53.07
  • ELTX 69.91
  • Support Level
  • IH $2.57
  • ELTX $11.05
  • Resistance Level
  • IH $2.84
  • ELTX $12.13
  • Average True Range (ATR)
  • IH 0.17
  • ELTX 0.75
  • MACD
  • IH -0.02
  • ELTX 0.19
  • Stochastic Oscillator
  • IH 68.09
  • ELTX 84.14

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: